Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Targeting the undruggable: immunotherapy meets personalized oncology in the genomic era

15 Sept 2015

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to CAR-T cell therapy research
Share to Immunotherapy and Immune Responses

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 26371284
DOI: 10.1093/annonc/mdv382

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Targeting the undruggable: immunotherapy meets personalized oncology in the genomic eraPMID 26371284Read ↗

The regulatory landscape for actively personalized cancer immunotherapiesSemantic proximity Read ↗

Cancer management in the era of immunotherapy: much more than meets the eye.Semantic proximity Read ↗

Personalized Oncology Meets Immunology: The Path toward Precision Immunotherapy.Semantic proximity Read ↗

Pharmacogenomic landscape of patient-derived tumor cells informs precision oncology therapySemantic proximity Read ↗

Twenty-First Century Precision Medicine in Oncology: Genomic Profiling in Patients With CancerSemantic proximity Read ↗

Achieving personalized cancer medicine: trials and tribulations.Semantic proximity Read ↗

Towards a better cancer precision medicine: Systems biology meets immunotherapySemantic proximity Read ↗

Genomics-Guided Immunotherapy for Precision Medicine in CancerSemantic proximity Read ↗

Precision oncology: where next?Semantic proximity Read ↗

Genome-based cancer therapeutics: targets, kinase drug resistance and future strategies for precision oncologySemantic proximity Read ↗

Druggable genome and precision medicine in cancer: current challengesSemantic proximity Read ↗

Estimation of the Percentage of US Patients With Cancer Who Benefit From Genome-Driven OncologySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.